Israeli co Pluri launches cell-based coffee
Israeli biotech company Pluri (Nasdaq: PLUR; TASE: PLUR) (formerly Pluristem Therapeutics) has announced that it has launched its cell-based coffee business activity. Pluri’s cell-based coffee product is designed to…
